Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

E. I. Andersson; S. Pützer; B. Yadav; O. Dufva; S. Khan; L. He; L Sellner; A Schrader; G Crispatzu; M Oleś; H. Zhang; S. Adnan-Awad; S. Lagström; D Bellanger; J. P. Mpindi; S. Eldfors; T. Pemovska; P. Pietarinen; A. Lauhio; K Tomska; C Cuesta-Mateos; E Faber; S Koschmieder; T H Brümmendorf; S. Kytölä; E-R Savolainen; T Siitonen; P. Ellonen; O. Kallioniemi; K. Wennerberg; W Ding; M-H Stern; W Huber; S. Anders; J. Tang; T. Aittokallio; T Zenz; M Herling; S. Mustjoki

doi:10.1038/leu.2017.252

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

E. I. Andersson, S. Pützer, B. Yadav, O. Dufva, S. Khan, L. He, L Sellner, A Schrader, G Crispatzu, M Oleś, H. Zhang, S. Adnan-Awad, S. Lagström, D Bellanger, J. P. Mpindi, S. Eldfors, T. Pemovska, P. Pietarinen, A. Lauhio, K TomskaC Cuesta-Mateos, E Faber, S Koschmieder, T H Brümmendorf, S. Kytölä, E-R Savolainen, T Siitonen, P. Ellonen, O. Kallioniemi, K. Wennerberg, W Ding, M-H Stern, W Huber, S. Anders, J. Tang, T. Aittokallio, T Zenz, M Herling, S. Mustjoki

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Leukemia
Volume	32
Issue number	3
Pages (from-to)	774-787
Number of pages	14
ISSN	0887-6924
DOIs	https://doi.org/10.1038/leu.2017.252
Publication status	Published - Mar 2018
MoE publication type	A1 Journal article-refereed

Fields of Science

3122 Cancers

Access to Document

10.1038/leu.2017.252

FIMM Sequencing
Pekka Ellonen (Manager)
Institute for Molecular Medicine Finland
Facility/equipment: Equipment

Cite this

Andersson, E. I., Pützer, S., Yadav, B., Dufva, O., Khan, S., He, L., Sellner, L., Schrader, A., Crispatzu, G., Oleś, M., Zhang, H., Adnan-Awad, S., Lagström, S., Bellanger, D., Mpindi, J. P., Eldfors, S., Pemovska, T., Pietarinen, P., Lauhio, A., ... Mustjoki, S. (2018). Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. Leukemia, 32(3), 774-787 . https://doi.org/10.1038/leu.2017.252

Andersson, E. I. ; Pützer, S. ; Yadav, B. ; Dufva, O. ; Khan, S. ; He, L. ; Sellner, L ; Schrader, A ; Crispatzu, G ; Oleś, M ; Zhang, H. ; Adnan-Awad, S. ; Lagström, S. ; Bellanger, D ; Mpindi, J. P. ; Eldfors, S. ; Pemovska, T. ; Pietarinen, P. ; Lauhio, A. ; Tomska, K ; Cuesta-Mateos, C ; Faber, E ; Koschmieder, S ; Brümmendorf, T H ; Kytölä, S. ; Savolainen, E-R ; Siitonen, T ; Ellonen, P. ; Kallioniemi, O. ; Wennerberg, K. ; Ding, W ; Stern, M-H ; Huber, W ; Anders, S. ; Tang, J. ; Aittokallio, T. ; Zenz, T ; Herling, M ; Mustjoki, S. / Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. In: Leukemia. 2018 ; Vol. 32, No. 3. pp. 774-787 .

@article{f935182e62dd4606bcacc7b13ed80d10,

title = "Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling",

keywords = "3122 Cancers",

author = "Andersson, {E. I.} and S. P{\"u}tzer and B. Yadav and O. Dufva and S. Khan and L. He and L Sellner and A Schrader and G Crispatzu and M Ole{\'s} and H. Zhang and S. Adnan-Awad and S. Lagstr{\"o}m and D Bellanger and Mpindi, {J. P.} and S. Eldfors and T. Pemovska and P. Pietarinen and A. Lauhio and K Tomska and C Cuesta-Mateos and E Faber and S Koschmieder and Br{\"u}mmendorf, {T H} and S. Kyt{\"o}l{\"a} and E-R Savolainen and T Siitonen and P. Ellonen and O. Kallioniemi and K. Wennerberg and W Ding and M-H Stern and W Huber and S. Anders and J. Tang and T. Aittokallio and T Zenz and M Herling and S. Mustjoki",

year = "2018",

month = mar,

doi = "10.1038/leu.2017.252",

language = "English",

volume = "32",

pages = "774--787 ",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "3",

}

Andersson, EI, Pützer, S, Yadav, B , Dufva, O , Khan, S , He, L, Sellner, L, Schrader, A, Crispatzu, G, Oleś, M, Zhang, H, Adnan-Awad, S, Lagström, S, Bellanger, D, Mpindi, JP, Eldfors, S, Pemovska, T, Pietarinen, P, Lauhio, A, Tomska, K, Cuesta-Mateos, C, Faber, E, Koschmieder, S, Brümmendorf, TH, Kytölä, S, Savolainen, E-R, Siitonen, T, Ellonen, P , Kallioniemi, O , Wennerberg, K, Ding, W, Stern, M-H, Huber, W, Anders, S, Tang, J , Aittokallio, T, Zenz, T, Herling, M & Mustjoki, S 2018, 'Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling', Leukemia, vol. 32, no. 3, pp. 774-787 . https://doi.org/10.1038/leu.2017.252

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. / Andersson, E. I.; Pützer, S.; Yadav, B.; Dufva, O.; Khan, S.; He, L.; Sellner, L; Schrader, A; Crispatzu, G; Oleś, M; Zhang, H.; Adnan-Awad, S.; Lagström, S.; Bellanger, D; Mpindi, J. P.; Eldfors, S.; Pemovska, T.; Pietarinen, P.; Lauhio, A.; Tomska, K; Cuesta-Mateos, C; Faber, E; Koschmieder, S; Brümmendorf, T H; Kytölä, S.; Savolainen, E-R; Siitonen, T; Ellonen, P.; Kallioniemi, O.; Wennerberg, K.; Ding, W; Stern, M-H; Huber, W; Anders, S.; Tang, J.; Aittokallio, T.; Zenz, T; Herling, M; Mustjoki, S.

In: Leukemia, Vol. 32, No. 3, 03.2018, p. 774-787 .

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

AU - Andersson, E. I.

AU - Pützer, S.

AU - Yadav, B.

AU - Dufva, O.

AU - Khan, S.

AU - He, L.

AU - Sellner, L

AU - Schrader, A

AU - Crispatzu, G

AU - Oleś, M

AU - Zhang, H.

AU - Adnan-Awad, S.

AU - Lagström, S.

AU - Bellanger, D

AU - Mpindi, J. P.

AU - Eldfors, S.

AU - Pemovska, T.

AU - Pietarinen, P.

AU - Lauhio, A.

AU - Tomska, K

AU - Cuesta-Mateos, C

AU - Faber, E

AU - Koschmieder, S

AU - Brümmendorf, T H

AU - Kytölä, S.

AU - Savolainen, E-R

AU - Siitonen, T

AU - Ellonen, P.

AU - Kallioniemi, O.

AU - Wennerberg, K.

AU - Ding, W

AU - Stern, M-H

AU - Huber, W

AU - Anders, S.

AU - Tang, J.

AU - Aittokallio, T.

AU - Zenz, T

AU - Herling, M

AU - Mustjoki, S.

PY - 2018/3

Y1 - 2018/3

KW - 3122 Cancers

U2 - 10.1038/leu.2017.252

DO - 10.1038/leu.2017.252

M3 - Article

VL - 32

SP - 774

EP - 787

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

Fields of Science

Access to Document

FIMM Sequencing

Cite this